Walmart Inc. (WMT)

This article compares Constellation Energy (CEG) and Vistra Corp. (VST) as investment opportunities in the nuclear utility sector. While both companies are well-positioned to benefit from growing demand for nuclear power, the analysis highlights Vistra's better earnings estimate movements, stronger Return on Equity, cheaper valuation, and healthier net margin, suggesting it currently has an edge over Constellation Energy despite both holding a Zacks Rank #3 (Hold). The article details their financial performance, growth projections, generation capacity, and debt levels to support its conclusion.

Flputnam Investment Management Co. significantly increased its stake in Fastenal Company (NASDAQ:FAST) by 797.6% in the second quarter, bringing its total holdings to $3.65 million. Other institutional investors also made substantial investments in Fastenal, which now has 81.38% institutional ownership. Despite some insider selling, analysts maintain a "Hold" rating on the stock with an average price target of $49.17, while Fastenal also recently increased its quarterly dividend.

Rivian's CFO, Claire McDonough, who guided the company through its 2021 IPO, is leaving the electric vehicle manufacturer to join GE Vernova. She will assume her new role on January 1. This move marks a significant change in leadership for Rivian.

Capital Advisors Inc. OK increased its stake in Blackstone Inc. by 35.2% in the second quarter, purchasing 87,885 additional shares to bring its total holdings to 337,510 shares valued at approximately $39.7 million. Institutional investors now own 70% of Blackstone's stock. The company recently reported strong quarterly earnings of $1.52 per share, exceeding estimates, with revenue rising 35.9% year over year, and analysts maintain a "Moderate Buy" consensus rating for the stock.

The Canada Pension Plan Investment Board acquired a new stake of 55,511 shares in ResMed Inc. (NYSE:RMD) during the second quarter, valued at approximately $10.8 million. Other institutional investors have also adjusted their holdings in ResMed, with the company's stock currently having a market cap of $34.69 billion and trading at $240.47. ResMed recently announced a quarterly dividend increase and reported strong earnings, though analysts have provided mixed ratings and price targets.